Insmed Incorporated (IM8N)
FSX
90.60
-1.40 (-1.52%)
Real-time Data
06:00 AM
Day's Range
90.6091.26
52 wk Range
78.77185.00
Financial Statements - IM8N - Insmed Incorporated
Revenue
606.42M▲ 96.8%
Net Income
-1.27B▼ 65.0%Net Margin -210.5%
EBITDA
-986.38M▼ 49.3%
Free Cash Flow
-967.57M▼ 61.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 606.42M | 308.08M | 305.20M | 245.35M | 188.46M | 164.41M |
| Cost of Goods | 122.93M | 72.62M | 65.57M | 55.12M | 44.15M | 39.87M |
| Gross Profit | 483.48M | 235.45M | 239.63M | 190.23M | 144.30M | 124.54M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -994.77M | -666.27M | -680.92M | -478.12M | -367.76M | -265.23M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -193.17M | -32.68M | 15.61M | 24.41M | -28.17M | 2.10M |
| Pre Tax Income | -1.27B | -770.87M | -747.01M | -480.15M | -436.41M | -292.68M |
| Income Tax | 5.02M | 3.14M | 2.55M | 1.38M | -1.75M | 1.40M |
| Net Income | -1.27B | -774.01M | -749.56M | -481.53M | -434.65M | -294.09M |
| EPS Basic | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 |
| EPS Diluted | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 |
| Basic Shares Outstanding | 199.01M | 138.95M | 147.50M | 126.33M | 115.11M | 100.21M |
| Diluted Shares Outstanding | 199.01M | 138.95M | 147.50M | 126.33M | 115.11M | 100.21M |
| Ebit | -1.19B | -702.89M | -670.75M | -457.69M | -397.82M | -264.52M |
| Ebitda | -986.38M | -660.86M | -673.93M | -477.72M | -358.79M | -252.07M |
| Net Income Continuous Operations | -1.27B | -774.01M | -749.56M | -481.53M | -434.65M | -294.09M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
